drugset / Trial / NCT07186413

A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris

NCT07186413

Phase 3 Recruiting 561 enrolled Galderma R&D
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective is to assess the efficacy of trifarotene 50 microgram per gram (mcg/g) cream versus vehicle cream when applied once daily (QD) for 12 weeks in Chinese participants with moderate facial and truncal acne vulgaris.

Timeline

Start
2025-09-23
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Trifarotene Small molecule 50 unknown Topical

Indications